In hepatocellular carcinoma, blockade of the BTLA-HVEM pathway increases lymphocyte IFN-γ production, suggesting that BTLA inhibits the antitumor response [297,298,299]. The gene discussed is BTLA; the disease is hepatocellular carcinoma.